| (USD) | Sep 2021 | Y/Y change |
|---|---|---|
| Revenue | 96.38K | — |
| Operating expense | — | — |
| Net income | -2.44M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NAVBQ returned -80.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.0% |
| 1 year | -80.0% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $390.00 (Jan 1996) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NAVBQ would be worth today ›No. Navidea Biopharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Navidea Biopharmaceuticals, Inc. is part of the Healthcare sector.
Navidea Biopharmaceuticals, Inc. has a market cap of 10.01K USD, based on the latest quote.